Cargando…

Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes

Soft tissue sarcomas (STS) are diverse tumors with heterogenous alterations. Platforms to detect circulating tumor DNA (ctDNA) have rapidly increased in popularity as they may avoid invasive biopsy morbidity. However, ctDNA profiling concordance with standard solid tumor comprehensive genomic profil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demoret, Bryce, Gregg, Jeff, Liebner, David A., Tinoco, Gabriel, Lenobel, Scott, Chen, James L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966562/ https://www.ncbi.nlm.nih.gov/pubmed/31766329 http://dx.doi.org/10.3390/cancers11121829

Ejemplares similares

Clinical markers of immunotherapy outcomes in advanced sarcoma
por: Husain, Marium, et al.
Publicado: (2023)

Significance of Circulating Tumor Cells in Soft Tissue Sarcoma
por: Nicolazzo, Chiara, et al.
Publicado: (2015)

Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis
por: Quiroga, Dionisia, et al.
Publicado: (2020)

Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue
por: Leenanitikul, Julanee, et al.
Publicado: (2023)

The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

Concordance of Genomic Alterations between Circulating Tumor DNA and Matched Tumor Tissue in Chinese Patients with Breast Cancer
por: Xu, Bing, et al.
Publicado: (2020)

Therapeutic Response-Based Reclassification of Multiple Tumor Subtypes Reveals Intrinsic Molecular Concordance of Therapy Across Histologically Disparate Cancers
por: Xu, Yue, et al.
Publicado: (2021)

Prognostic impact of circulating tumor cells in patients with soft‐tissue sarcomas: a prospective study
por: Blanchi, Julie, et al.
Publicado: (2023)

Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma
por: Wu, Changwu, et al.
Publicado: (2022)

Emerging Trends in Immunotherapy for Adult Sarcomas
por: Husain, Marium, et al.
Publicado: (2023)

Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer
por: Wang, Ruiliang, et al.
Publicado: (2023)

Locus‐specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma
por: Calapre, Leslie, et al.
Publicado: (2018)

Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast Cancer
por: Huang, Chi-Cheng, et al.
Publicado: (2023)

The PTEN Tumor Suppressor Gene in Soft Tissue Sarcoma
por: Stefano, Sioletic, et al.
Publicado: (2019)

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas
por: Blanchi, Julie, et al.
Publicado: (2023)

Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy
por: Barretina, Jordi, et al.
Publicado: (2010)

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
por: Chae, Young Kwang, et al.
Publicado: (2016)

Signatures of circulating microRNA in four sarcoma subtypes
por: Kosela-Paterczyk, Hanna, et al.
Publicado: (2020)

Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study
por: Li, Shih-Hong, et al.
Publicado: (2022)

Identification of m(5)C-related molecular subtypes and prediction models in the prognosis and tumor microenvironment infiltration of soft tissue sarcoma
por: Wang, Xianfeng, et al.
Publicado: (2023)

Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population
por: Rosenberg, Shai, et al.
Publicado: (2023)

Randomized Prospective Trial Exploring the Impact of Structured Journaling in Patients With Sarcoma on the Management of Treatment-Related Adverse Events
por: Speece, N.J., et al.
Publicado: (2022)

Should tumor depth be included in prognostication of soft tissue sarcoma?
por: Rydholm, Anders, et al.
Publicado: (2003)

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis
por: He, Yiping, et al.
Publicado: (2020)

Synovial sarcoma of bone: Sarcoma typically of soft tissues presenting as a primary bone tumor
por: Caracciolo, Jamie T., et al.
Publicado: (2018)

Circulating tumour-derived DNA in metastatic soft tissue sarcoma
por: Eastley, Nicholas C., et al.
Publicado: (2018)

Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden
por: Raj, Shailaja K. S., et al.
Publicado: (2022)

Absence of Telomerase Activity in Malignant Bone Tumors and Soft-Tissue Sarcomas
por: Lauer, Nina K., et al.
Publicado: (2002)

Tumor grading of soft tissue sarcomas using MRI-based radiomics
por: Peeken, Jan C., et al.
Publicado: (2019)

Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy
por: Sousa, Luana Madalena, et al.
Publicado: (2021)

Descriptive epidemiology of soft tissue sarcomas and gastrointestinal stromal tumors in Thailand
por: Klangjorhor, Jeerawan, et al.
Publicado: (2022)

Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
por: Agnoletto, Chiara, et al.
Publicado: (2021)

Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy
por: Tuna, Musaffe, et al.
Publicado: (2012)

Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China
por: Yang, Zhixun, et al.
Publicado: (2019)

Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer
por: Tan, Chye Ling, et al.
Publicado: (2016)

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma
por: Seligson, Nathan D., et al.
Publicado: (2019)

YKL-40 expression in soft-tissue sarcomas and atypical lipomatous tumors: An immunohistochemical study of 49 tumors
por: Harving, Mette L, et al.
Publicado: (2014)

Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer
por: Taavitsainen, Sinja, et al.
Publicado: (2019)

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma
por: Mukaihara, Kenta, et al.
Publicado: (2017)

Outcomes of Vascular Resection and Reconstruction in Extremity Soft Tissue Sarcoma and Bone Tumors
por: Shah, Anand Chetan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oe9cu8m8f1l0071jkom6faudlu